Page last updated: 2024-08-21

triphenyltetrazolium and tacrolimus

triphenyltetrazolium has been researched along with tacrolimus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abumiya, T; Ikeda, J; Iwasaki, Y; Kobayashi, T; Kuroda, S; Shichinohe, H; Yoshimoto, T	1

Other Studies

1 other study(ies) available for triphenyltetrazolium and tacrolimus

Article	Year
FK506 reduces infarct volume due to permanent focal cerebral ischemia by maintaining BAD turnover and inhibiting cytochrome c release. Brain research, 2004, Mar-19, Volume: 1001, Issue:1-2 Topics: Analysis of Variance; Animals; bcl-Associated Death Protein; Blotting, Western; Brain Infarction; Carrier Proteins; Cytochromes c; Dose-Response Relationship, Drug; Immunohistochemistry; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred BALB C; Neocortex; Phosphorylation; Tacrolimus; Tetrazolium Salts; Time Factors	2004

Article

Year

FK506 reduces infarct volume due to permanent focal cerebral ischemia by maintaining BAD turnover and inhibiting cytochrome c release.

Brain research, 2004, Mar-19, Volume: 1001, Issue:1-2

Topics: Analysis of Variance; Animals; bcl-Associated Death Protein; Blotting, Western; Brain Infarction; Carrier Proteins; Cytochromes c; Dose-Response Relationship, Drug; Immunohistochemistry; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred BALB C; Neocortex; Phosphorylation; Tacrolimus; Tetrazolium Salts; Time Factors

2004